Some ‘cheap’ biotech stocks that could be buyout targets, RBC says
January 25, 2016 at 12:58 PM EST
RBC Capital analysts pick out nine biotechnology stocks they cover that are trading below or just slightly above cash levels, which could make them buyout candidates for value investors.